You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Feasibility of investigating methylphenidate for the treatment of sarcoidosis-associated fatigue (the FaST-MP study): a double-blind, parallel-arm randomised feasibility trial

Article metrics

Article menu
XML
Interstitial lung disease
Feasibility of investigating methylphenidate for the treatment of sarcoidosis-associated fatigue (the FaST-MP study): a double-blind, parallel-arm randomised feasibility trial

 

Online download statistics by month:

Online download statistics by month: May 2021 to March 2024

AbstractFullPdf
May 202118718737
Jun 202110610646
Jul 2021434519
Aug 2021383814
Sep 2021383817
Oct 2021323324
Nov 2021554727
Dec 2021423810
Jan 202231313
Feb 2022272728
Mar 2022373717
Apr 2022515022
May 2022575422
Jun 2022444619
Jul 2022343213
Aug 2022424118
Sep 2022495134
Oct 2022697010
Nov 2022252417
Dec 2022282610
Jan 2023262611
Feb 2023454718
Mar 2023252219
Apr 202316155
May 2023181819
Jun 202314139
Jul 2023454420
Aug 202315156
Sep 202322229
Oct 202314165
Nov 202328288
Dec 2023352915
Jan 202435282
Feb 2024191912
Mar 2024322876
Total14241391641